Article Text
Abstract
A young woman with systemic lupus erythematosus (SLE) developed recurrent enterovirus meningoencephalitis while taking prednisolone, azathioprine and rituximab. After reducing the immunosuppression, she developed a central nervous system (CNS) flare of SLE, with enterovirus still present in the cerebrospinal fluid (CSF). There are no evidence-based specific treatments for enterovirus encephalitis, but she responded well to intravenous immunoglobulin alongside pulsed methylprednisolone and rituximab. This case highlights the difficulties in managing people with co-existing infective and autoimmune conditions, especially if each affects the CNS. A viral infection and SLE flare can resemble one another clinically, although here the radiological differentiation of CNS lupus versus enterovirus encephalitis helped to guide the diagnosis.
- neurovirology
- SLE
- encephalitis
- infectious diseases
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Rhomboencephalitis
- Fifteen-minute consultation: enterovirus meningitis and encephalitis—when can we stop the antibiotics?
- Infectious encephalitis: mimics and chameleons
- Lupus myelopathy
- Leucoencephalopathy with progressive cerebral atrophy
- Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection
- Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme
- Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus
- Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus
- Mimics and chameleons in Guillain–Barré and Miller Fisher syndromes